These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27879540)

  • 1. Severe Hemolytic Anemia Following Intravenous Immunoglobulin in an Infant With Kawasaki Disease.
    Tocan V; Inaba A; Kurano T; Sonoda M; Soebijanto K; Nakayama H
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e100-e102. PubMed ID: 27879540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.
    Luban NL; Wong EC; Henrich Lobo R; Pary P; Duke S
    Transfusion; 2015 Jul; 55 Suppl 2():S90-4. PubMed ID: 26174904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune haemolytic anaemia caused by anti-M antibody in a patient with Kawasaki disease.
    Shimomura M; Okura Y; Ohta O; Takahashi Y; Kobayashi I
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):99-101. PubMed ID: 33086950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease.
    Nolan BE; Wang Y; Pary PP; Luban NLC; Wong ECC; Ronis T
    Transfusion; 2018 Nov; 58(11):2564-2571. PubMed ID: 30265742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of autoimmune hemolytic anemia with anti-D specificity in a 1-year-old child.
    Bercovitz RS; Macy M; Ambruso DR
    Immunohematology; 2013; 29(1):15-8. PubMed ID: 24046918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease.
    Nakagawa M; Watanabe N; Okuno M; Kondo M; Okagawa H; Taga T
    Am J Hematol; 2000 Mar; 63(3):160-1. PubMed ID: 10679809
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe immune haemolytic anaemia caused by intravenous immunoglobulin anti-D in the treatment of autoimmune thrombocytopenia.
    Barbolla L; Nieto S; Llamas P; Moreno C; Contreras M; Lubenko A; Garner S
    Vox Sang; 1993; 64(3):184-5. PubMed ID: 8484253
    [No Abstract]   [Full Text] [Related]  

  • 8. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine.
    Salama A; Mueller-Eckhardt C
    Blood; 1986 Dec; 68(6):1285-8. PubMed ID: 3096400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone.
    Goto M; Miyagawa N; Kikunaga K; Miura M; Hasegawa Y
    Endocr J; 2015; 62(2):145-51. PubMed ID: 25342092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease.
    Cheon EJ; Oh JS
    BMC Pediatr; 2024 Jan; 24(1):69. PubMed ID: 38245705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: exacerbation of hemolytic anemia requiring multiple incompatible RBC transfusions.
    Svensson AM; Bushor S; Fung MK
    Immunohematology; 2004; 20(3):177-83. PubMed ID: 15373649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune hemolytic anemia predominantly associated with IgA anti-E and anti-c.
    Lim YA; Kim MK; Hyun BH
    J Korean Med Sci; 2002 Oct; 17(5):708-11. PubMed ID: 12378029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products.
    Bruggeman CW; Nagelkerke SQ; Lau W; Manlhiot C; de Haas M; van Bruggen R; McCrindle BW; Yeung RSM; Kuijpers TW
    Blood Adv; 2020 Jul; 4(14):3416-3426. PubMed ID: 32722782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second example of hemolysis due to IgA autoantibody with anti-e specificity.
    Girelli G; Perrone MP; Adorno G; Arista MC; Coluzzi S; Damico C; di Giorgio G; Monarca B
    Haematologica; 1990; 75(2):182-3. PubMed ID: 2113509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanisms for intravenous immunoglobulin-associated hemolysis: clues obtained from review of clinical case reports.
    Padmore R
    Transfusion; 2015 Jul; 55 Suppl 2():S59-64. PubMed ID: 26174898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.
    Ajmi H; Mabrouk S; Hassayoun S; Regaieg H; Tfifha M; Jalel C; Skouri H; Zouari N; Abroug S
    J Med Case Rep; 2017 Nov; 11(1):321. PubMed ID: 29132419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
    Tsujimoto H; Takeshita S; Nakatani K; Kawamura Y; Tokutomi T; Sekine I
    Clin Immunol; 2002 May; 103(2):161-8. PubMed ID: 12027421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hemolytic anemia caused by anti-D.
    Adams J; Moore VK; Issitt PD
    Transfusion; 1973; 13(4):214-8. PubMed ID: 4198438
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of ulcerative colitis showing anti-Rh (e)autoantibody associated with autoimmune hemolytic anemia].
    Yoshida Y; Yamano Y; Yamamura M; Kobayashi S; Imai K; Yabana T; Yachi A; Fukuda Y; Ban N; Hata E
    Nihon Naika Gakkai Zasshi; 1991 Aug; 80(8):1286-8. PubMed ID: 1919249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.